Smoking Linked to Cognitive Decline in Children: Study

Aug.31.2022
Smoking Linked to Cognitive Decline in Children: Study
Smoking linked to poor cognitive performance and brain volume reduction in children, per a 2-year study on 1000+ children in Nebraska, US.

A study conducted in the state of Nebraska, United States revealed that smoking is associated with poor cognitive performance and reduced brain volume among more than 1,000 children aged 9 to 10 years old who were followed up for two years. The study found that the effects of smoking could have a lasting impact.


Among those investigated, 116 children reported using tobacco products and were considered to be the earliest group of tobacco users in the study. This group performed poorly on the tests (mean, b = -2.9; SE, 0.6; P <.001), showing lower crystallized cognitive composite scores (b = -2.4; SE, 0.5; P <.001) and total cognitive composite scores (b = -2.9; SE, 0.5; P = .01). In a follow-up study of two years, smokers had lower cortical volumes in the frontal, parietal, and temporal lobes than non-users.


According to a report by Dr. Hongying Daisy Dai, Chief Researcher at the University of Nebraska Medical Center, electronic cigarettes and smokeless tobacco products should not be considered as a substitute to traditional cigarettes for youth to reduce tobacco-related harm. Authorities should implement comprehensive intervention strategies and tobacco control policies to prevent tobacco initiation.


From October 2016 to October 2018, a study titled Adolescent Brain Cognitive Development (ABCD) included 11,729 children from 21 US-based websites. This study followed up with the participants from August 2018 to January 2021. Participants were asked to complete a survey about tobacco use, including e-cigarettes, cigarettes, cigars, smokeless tobacco, hookah, pipes, and nicotine replacement products.


Dai and colleagues utilized a comprehensive combination of cognitive assessment measures, including the National Institutes of Health Toolbox Cognitive Battery, morphometric analysis, and structural MRI, to evaluate differences between users and non-users. In terms of race and ethnicity, 2.1% of the sample were Asian; 20.3% were Hispanic/Latino; 14.9% were non-Hispanic Black; and 52.1% were non-Hispanic White. Just over a quarter (27.3%) of the sample had parents who were college graduates, and 13.7% had parents with an annual income less than $25,000.


During a two-year follow-up period, the scores of first-time tobacco users in oral recognition (b=-2.1; SE, 0.5; P<.001), picture sequencing memory (b=-3.0; SE, 0.7; P<.001), and crystallized cognitive composite scores (b=-2.7; SE, 0.8; P=.005) remained lower than non-users. In SMRI analysis, former smokers exhibited significantly decreased measurements in the entire brain, including the total cortical surface area in the first wave (b=-5014.8 mm3; SE, 7043.9; P=.002), total cortical volume in the first wave (b=-174,621.0 mm3; SE, 5857.7; P=.003) and follow-up (b=-21,790.8 mm3; SE, 7043.9; P=.002), and total intracranial volume in the first wave (b=-38,442.8 mm3; SE, 12,057.7; P=.009).


In a related editorial, Dr. Laviolette from the University of Western Ontario wrote, "The findings reported by Dai and colleagues raise many important questions for future clinical and preclinical investigations. It is important to determine the extent to which these pathophysiological findings extend beyond the window of brain maturation prior to adolescence. Furthermore, it is crucial to identify the specific molecular mechanisms and biomarkers underlying these persistent tobacco-induced pathophysiological effects.


He added that the description of potential mechanisms could facilitate similar identification of intervention and reversal strategies for "neurological and psychiatric phenotypes caused by nicotine exposure in children, adolescents, and even prenatal exposure." Additionally, advances in genomic and transcriptomic analysis could better understand the potential genetic factors that could make individuals more susceptible to nicotine products during critical periods of brain development, as well as factors that could increase the risk of serious neurological and cognitive outcomes after exposure to nicotine during the developmental window for some individuals.


Statement: 1. This article's content is based on the compilation of third-party information and is intended solely for industry exchanges and learning purposes. 2. The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is for industry exchange and research purposes only. 3. Due to limited compilation skills, the translated article may not fully reflect the original text. Please refer to the original text for accuracy. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, or international statements or positions, 2FIRSTS is fully aligned with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. Please contact us for removal if there are any infringements.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Wales Passes Law Banning Tobacco Sales to Anyone Born After 2009
Wales Passes Law Banning Tobacco Sales to Anyone Born After 2009
The Welsh Parliament (Senedd) has approved new legislation banning tobacco sales to anyone born on or after January 1, 2009. The law, passed on December 9, 2025, also imposes stricter controls on how vapes and nicotine products are advertised and sold. Designed by the UK Government but voted on separately in Wales, the bill passed with 36 votes in favor, two abstentions, and nine against. It grants stronger enforcement powers to Trading Standards to combat illegal tobacco and vape sales.
Dec.10 by 2FIRSTS.ai
Mexican Senate Approves Nationwide Ban on E-Cigarettes and Vapes
Mexican Senate Approves Nationwide Ban on E-Cigarettes and Vapes
Mexico’s Senate passed a reform to the General Health Law banning the production, importation, sale, and advertising of e-cigarettes and vape products nationwide. The bill passed with 76 votes in favor, 37 against, and one abstention.
Dec.12 by 2FIRSTS.ai
1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly
1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly
Over 1,200 UK health leaders urged Parliament to pass the Tobacco and Vapes Bill quickly, calling it vital to protect future generations. The bill would ban tobacco sales to anyone born after Jan 1, 2009, and restrict vape packaging and flavours. Health groups warned delays risk undermining “gamechanging” public health reforms.
Oct.27 by 2FIRSTS.ai
EU to consider Denmark's proposal for stricter tobacco tax reforms. Heating tobacco tax could increase by 132%, nicotine pouch tax by up to 1000%. 92% opposed to overall tax hike in public consultation. Concerns raised over taxing innovative smoke-free pr
EU to consider Denmark's proposal for stricter tobacco tax reforms. Heating tobacco tax could increase by 132%, nicotine pouch tax by up to 1000%. 92% opposed to overall tax hike in public consultation. Concerns raised over taxing innovative smoke-free pr
EU to debate Denmark's proposal to increase tobacco taxes, including a 132% hike for heated tobacco and 1000% for nicotine pouches.
Dec.04 by 2FIRSTS.ai
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
British American Tobacco (BAT) reaffirmed its 2026 guidance while announcing a £1.3 billion (approximately USD 1.65 billion) share buyback for FY26. The company expects around 2% growth in revenue and adjusted profit from operations for FY25. Accelerating New Category growth, driven by Velo Plus and improving U.S. Vuse performance, is expected to deliver double-digit H2 revenue growth.
Dec.09 by 2FIRSTS.ai
Thailand Seizes Over 42,000 Illegal Vapes Worth USD 340,000
Thailand Seizes Over 42,000 Illegal Vapes Worth USD 340,000
Thai authorities announced the seizure of more than 42,000 smuggled vapes worth approximately THB 10.87 million (USD 340,000).
Dec.12 by 2FIRSTS.ai